792 results on '"Mahler, Donald A."'
Search Results
2. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
3. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
4. Systematic review of the effects of patient errors using inhaled delivery systems on clinical outcomes in COPD
5. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
6. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers
7. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease
8. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
9. Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium
10. Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease
11. Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.
12. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study
13. Dyspnoea
14. Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
15. Phase III Clinical Efficacy of Indacaterol: Patient-Centered Outcomes
16. Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
17. Dexamethasone for cancer-related dyspnoea – Authors' reply
18. A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary Disease
19. Preface
20. Alleviating breathlessness in patients with cancer with dexamethasone (ABCD): A parallel-group, double-blind, randomized clinical trial (RCT).
21. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity
22. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
23. Inflammation in COPD: Implications for Management
24. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD
25. COPD
26. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study
27. Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
28. Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD
29. A Color Sound Film to Illustrate the Use of New Materials and Techniques in Teaching Emotionally and/or Neurologically Handicapped Minors. Final Report.
30. FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease
31. Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases
32. Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy
33. American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease
34. TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
35. Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD
36. Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
37. A Perspective on Web-based Information for Patients with Chronic Lung Disease
38. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
39. Recent Advances in Dyspnea
40. Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
41. Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD
42. Response
43. One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
44. Other Treatments for Dyspnea
45. Neurobiology of Dyspnea: An Overview
46. Effect of Bronchodilators and Inhaled Corticosteroids on Dyspnea in Chronic Obstructive Pulmonary Disease
47. Chronic Dyspnea
48. Phase III Clinical Efficacy of Indacaterol: Patient-Centered Outcomes
49. Breathe Easy : Relieving the Symptoms of Chronic Lung Disease
50. REMOTELY RECORDED PEAK INHALATION FLOW PATTERNS AMONG PATIENTS WITH COPD USING PROAIR DIGIHALER FOR RESCUE MEDICATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.